This shows you the differences between two versions of the page.
Previous revision | |||
— | home:othertreatments:chemotherapy [09.14.2022] (current) – external edit 127.0.0.1 | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | ====== | ||
+ | |||
+ | < | ||
+ | |||
+ | |||
+ | In popular usage, chemotherapy refers to a chemical treatment used to kill or halt the replication and/or spread of cancerous cells in a patient. The use of chemotherapy is not limited to cancer. Chemotherapeutic agents have also been used, with marginal success, against inflammatory diseases such as sarcoidosis and against pathogenic infections infections such as hepatitis C. | ||
+ | |||
+ | There is no official recommendation on whether patients and their physicians should use chemotherapeutic agents against cancer. However, there are two primary concerns about chemotherapy: | ||
+ | * Chemotherapy is immunosuppressive and drastically weakens the body's natural ability to fight infection. | ||
+ | * Chemotherapy targets fast-growing cells, but fails to target chronic pathogens and human cells infected by chronic pathogens. | ||
+ | |||
+ | Those patients who take a regimen of chemotherapy should explore with their physicians the option of using the Marshall Protocol while on their chemotherapy. | ||
+ | |||
+ | The use of chemotherapeutic agents such as methotrexate (MTX) against sarcoidosis and other autoimmune diseases is not recommended. | ||
+ | |||
+ | |||
+ | ===== Effects of additional immunosuppression ===== | ||
+ | |||
+ | There are variety of kinds of chemotherapy, | ||
+ | |||
+ | When the body is immunosuppressed, | ||
+ | |||
+ | The additional immunosuppression caused by chemotherapy can cause symptoms over the long-term such as "chemo brain." | ||
+ | |||
+ | ==== Chemo brain ==== | ||
+ | |||
+ | Brain fog (also known as "chemo brain" | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | ===== Methotrexate ===== | ||
+ | |||
+ | < | ||
+ | |||
+ | Methotrexate (MTX) is an antibiotic, which interferes with bacteria' | ||
+ | |||
+ | |||
+ | ===== Rituximab ===== | ||
+ | |||
+ | |||
+ | In 2011, a Norwegian study published in //PLoS One// studied the effect of Rituximab – a monoclonal antibody otherwise used in cancers and anti-rejection treatment for organ transplants – on patients with chronic fatigue syndrome. In the 25-week study period, fatigue improved significantly in 10 out of 15 patients versus 2 out of 15 controls.(({{pmid> | ||
+ | |||
+ | ===== Patient interviews | ||
+ | |||
+ | |||
+ | < | ||
+ | <div class=" | ||
+ | |||
+ | <div class=" | ||
+ | <div class=" | ||
+ | <div class=" | ||
+ | <div class=" | ||
+ | |||
+ | sarcoidosis, | ||
+ | |||
+ | Read the [[https:// | ||
+ | |||
+ | < | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | < | ||
+ | |||
+ | |||
+ | |||
+ | <br clear=" | ||
+ | |||
+ | </ | ||
+ | </ | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | < | ||
+ | ===== Notes and comments ===== | ||
+ | |||
+ | |||
+ | |||
+ | * Legacy content | ||
+ | * https:// | ||
+ | * https:// | ||
+ | * https:// | ||
+ | * | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | < | ||
+ | |||
+ | |||
+ | 2. Mittra I. The disconnection between tumor response and survival. Nat Clin Pract Oncol. 2007; | ||
+ | 3. SavageL.High-intensitychemotherapydoesnotimprovesurvivalinsmallcelllung cancer. J Natl Cancer Inst. 2008; | ||
+ | |||
+ | //**H.H. Weng**// | ||
+ | |||
+ | Some more interesting stuff here: | ||
+ | https:// | ||
+ | |||
+ | In cancer research, system behavior has been monitored during cancer progression, | ||
+ | |||
+ | 9. Weng HH, Stevens J, Liu G; et al. Stochastic cancer progression driven by non-clonal chromosome aberrations. J Cell Physiol. 2006; | ||
+ | |||
+ | 10. Ye CJ, Liu G, Bremer SW; et al. The dynamics of cancer chromosome and genome. Cytogenet Genome Res. 2007; | ||
+ | </ | ||
+ | |||
+ | |||
+ | < | ||
+ | ===== References =====</ | ||